GLP-1 and the CNS Regulation of Appetite

GLP-1 and the CNS Regulation of Appetite is organized by Dannemiller, Inc

Release Date: January 01, 2019
Expiration Date: December 31, 2020

Intended Audience:
Physicians, Nurse Practitioners, Registered Dietitians, Registered Nurses.

Accreditation:
Physicians:
Dannemiller designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants:
PAs may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioners:
Dannemiller is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 090419. This program is accredited for 1.0 contact hours.

Registered Dietitians:
Dannemiller is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Crendentialed Practitioners will receive 1.0 Continuing Professional Education units (CPEUs) for completion of this material CDR Provider #DM002. Level 2 Activity.

Registered Nurses:
Dannemiller designates this educational activity for 1.00 contact hours.

Statement of Need:
As the obesity epidemic progresses, health care professionals should look toward educational forums to learn about the most modern advances in research, treatment, and best business practices to improve the quality of life for individuals who are obese and overweight. The conference promotes educational advancement by merging academic and clinical experts with professionals, and provides an opportunity for networking and the exchange of indispensable knowledge.

Learning Objectives:
Upon completion of this activity, the participant should be able to:
• Review peripheral biological mechanisms through which GLP-1 and GLP-1 analogs reduce food intake
• Identify brain regions through which GLP-1 and GLP-1 analogs act to reduce food intake
• Understand the role of nausea in the food intake reductions with GLP-1 analog treatment